Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
M.D. Anderson Cancer Center
Medical College of Wisconsin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Memorial Sloan Kettering Cancer Center
Bayer
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Y-mAbs Therapeutics
City of Hope Medical Center
Bristol-Myers Squibb
Children's Oncology Group
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Novartis
Children's Oncology Group
Celgene
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Fred Hutchinson Cancer Center
Novartis
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Eli Lilly and Company